HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polymorphisms in estrogen receptor-α are associated with idiopathic female infertility.

Abstract
To investigate the relationship between polymorphisms in the estrogen receptor-α (ERα) gene and unexplained female infertility, restriction fragment length polymorphism (RFLP) analysis of ERα was employed in 150 females with idiopathic infertility (study group) and 150 healthy, age-matched females of proven fertility (control group). The results showed that the ERα allele frequencies differed significantly between the study and control groups (P=0.001). The allele identified by PvuII (P) restriction was detected more frequently in the study group (49.0% of individuals) compared to the control group (31.0%; P=0.001), while the allele identified by XbaI (X) restriction was detected less frequently in the study group (19.7%) compared to the control group (35.7%, P=0.001). A similar phenomenon was observed for the distribution of the TA alleles. The TA13 allele was more common in the study group (24.7 vs. 6.7% in controls; P=0.001), while the TA15 allele was less common in the study group (15.3 vs. 27.3% in controls; P=0.034). To conclude, polymorphisms in the ERα gene are associated with idiopathic female infertility. In particular, the P and TA13 alleles may represent significant risk factors, while the X and TA15 alleles may be protective factors.
AuthorsJiu-Wei Du, Xin-Rong Tao, Ke-Yi Xu, Li-Yi Fang, Xin-Lan Qi
JournalMolecular medicine reports (Mol Med Rep) 2011 Nov-Dec Vol. 4 Issue 6 Pg. 1239-42 ISSN: 1791-3004 [Electronic] Greece
PMID21842124 (Publication Type: Journal Article)
Chemical References
  • Estrogen Receptor alpha
Topics
  • Adult
  • Alleles
  • Estrogen Receptor alpha (genetics)
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Infertility, Female (genetics)
  • Polymorphism, Restriction Fragment Length
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: